Geir Olve Skeie

Geir Olve Skeie has an MD and PhD from the University of Bergen. He is a consultant neurologist at the Department of Neurology and Senior Researcher at NEUROSYSMED, Haukeland University hospital. He has been a part of the PARKVEST study since 2004 doing mainly clinical research focusing on Parkinson’s Disease. He also has an interest

Lilah Toker

Lilah has a PhD in Clinical Biochemistry from Ben-Gurion University of the Negev, Beer Sheva, Israel. She has expertise in animal models, translational psychiatry, biochemistry and bioinformatics. Her PhD focused on animal models of psychiatric disorders, and her postdoc was in the Pavlidis lab, University of British Columbia, Vancouver, Canada, developing approaches for cell composition

Gonzalo S. Nido

Gonzalo Nido has a PhD in gene regulation from the Computer Science Department of the University of Otago, New Zealand. He is a bioinformatician with expertise in gene expression and mitochondrial genetics of neurodegeneration. His current work is centered in gene expression control in human brain, specifically in Parkinson Disease. ORCID: 0000-0002-1766-4108

Kristoffer Haugarvoll

Kristoffer Haugarvoll has an MD from the University of Göttingen. He is a neurologist with expertise in movement disorders, dementia and neurodegenerative disease. He did his PhD at the Department of Neuroscience at the Norwegian University of Science and Technology (NTNU) and Mayo Clinic Jacksonville, studying genetics of Parkinson’s disease (PD). He currently focuses on